www.fdanews.com/articles/84998-zeria-pharmaceutical-licenses-gastric-ulcer-drug-to-sk-chemicals
ZERIA PHARMACEUTICAL LICENSES GASTRIC ULCER DRUG TO SK CHEMICALS
March 3, 2006
Zeria Pharmaceutical announced on March 2 that it had concluded a licensing agreement with Korean company SK Chemicals as of February 27. Under the terms of the agreement, SK Chemicals is licensed to develop and sell Promac Granules 15%, ZERIA's proprietary ethical agent for the treatment of gastric ulcers, exclusively in Korea.
JCN Network (http://japancorp.net/Article.Asp?Art_ID=12016)